2012 annual financial data
Vistagen Therapeutics 2012 Operating margin
Direct answer
Operating margin was -673.77%.
Operating income was -9,043,400 USD and net income was -12,209,500 USD.
Operating cash flow was -3,565,800 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,342,200 USD
- Operating income
- -9,043,400 USD
- Net income
- -12,209,500 USD
- Operating cash flow
- -3,565,800 USD